EPO and neoplasm: In addition, tumour-related chronic inflammation can disrupt iron metabolism and alter erythropoietin (EPO) function (Su et al., 2021; Brigle et al., 2017), further exacerbating the cycle of anemia and bone marrow dysfunction.